Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen supplementation in letrozole-induced ovulation for PCOS
ChiCTR2500115444Phase 4Not yet recruiting
- Sponsor
- Dongguan People's Hospital
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of letrozole and estradiol in polycystic ovary syndrome (PCOS) and anovulatory infertility (2 arms), sponsored by Dongguan People's Hospital. Primary endpoint: Clinical pregnancy rate. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
letrozoleestradiol
03
Conditions
polycystic ovary syndrome (PCOS)anovulatory infertility
Beyond the preview
Go deeper on ChiCTR2500115444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115444.